Pooled Analysis of Tobacco Use and Risk of Parkinson Disease
Top Cited Papers
Open Access
- 1 July 2007
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 64 (7) , 990-997
- https://doi.org/10.1001/archneur.64.7.990
Abstract
Early case-control studies suggesting that patients with Parkinson disease (PD) are less likely to be smokers were criticized as biased. The observation is counterintuitive; cigarette smoke has long been recognized as a cause of adverse health effects. Thus, selective survival of PD cases and reporting bias were suggested as possible explanations. In the 1990s, reports from prospective cohort studies lent more credibility to the assertion that smoking may play a protective role in PD.1-3 Recent studies also suggested that PD risk is particularly low in active smokers with a long history of intense smoking; some even suggested dose-related risk reductions with increasing pack-years of smoking.3-7 This prompted speculation as to whether and how these observations might inform PD treatment and prevention.8Keywords
This publication has 8 references indexed in Scilit:
- SNP and haplotype variation in the human genomeMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2003
- Survival Study of Parkinson Disease in Olmsted County, MinnesotaArchives of Neurology, 2003
- MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PDNeurology, 2002
- Transdermal nicotine in PDNeurology, 2001
- Neuroprotection in the MPTP Parkinsonian C57BL/6 Mouse Model by a Compound Isolated from TobaccoChemical Research in Toxicology, 2001
- Current Evidence for Neuroprotective Effects of Nicotine and Caffeine Against Parkinson??s DiseaseDrugs & Aging, 2001
- Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990Neurology, 1999
- The D2 dopamine receptor gene, addiction, and personality: clinical correlates in cocaine abusersBiological Psychiatry, 1996